Effects of fumonisin B-1 treatment on blood-brain barrier transfer in developing rats

被引:17
作者
Kwon, OS
Sandberg, JA
Slikker, W
机构
[1] US FDA,NATL CTR TOXICOL RES,DIV NEUROTOXICOL HFT132,JEFFERSON,AR 72079
[2] UNIV ARKANSAS MED SCI HOSP,DEPT PHARMACOL & TOXICOL,LITTLE ROCK,AR 72205
关键词
fumonisin B-1; mycotoxin; sphinganine; sphingosine; blood-brain barrier; pharmacokinetics;
D O I
10.1016/S0892-0362(96)00217-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Fumonisin B-1 (FB1), a toxic metabolite of the fungus Fusarium moniliforme found in contaminated corn, is considered an etiologic agent of equine leukoencephalomalacia. Because FB1 exposure is associated with alteration of sphingolipid metabolism; the purpose of this study was to elucidate whether blood sphinganine (Sa) levels affect brain Sa levels. Sa and sphingosine (So) levels in brain tissue and plasma were analyzed by HPLC. Area under the curve (AUC(0-->24h)) ratios of brain Sa to plasma Sa levels were about 40 after a single 0.8 or 8 mg/kg SC dose of FB1. The AUC(0-->12h) ratio of brain FB1 to plasma FB1 was 0.02. The fact that FB1 alters brain Sa levels and Sa/So ratios indicates that sphingolipid metabolism in the central nervous system of developing rats is vulnerable to FB1 exposure. These data support our hypothesis that alterations of the brain Sa levels are related to the direct action of FB1 on the brain rather than transport of peripheral Sa to the brain. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:151 / 155
页数:5
相关论文
共 31 条
  • [1] LONG-CHAIN (SPHINGOID) BASES INHIBIT MULTISTAGE CARCINOGENESIS IN MOUSE C3H/10T1/2 CELLS TREATED WITH RADIATION AND PHORBOL 12-MYRISTATE 13-ACETATE
    BOREK, C
    ONG, A
    STEVENS, VL
    WANG, E
    MERRILL, AH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (05) : 1953 - 1957
  • [2] INCREASED BLOOD-BRAIN-BARRIER TRANSPORT OF PROTEIN-BOUND ANTI-CONVULSANT DRUGS IN THE NEWBORN
    CORNFORD, EM
    PARDRIDGE, WM
    BRAUN, LD
    OLDENDORF, WH
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1983, 3 (03) : 280 - 286
  • [3] FERGUSON SA, IN PRESS NEUROTOXICO
  • [4] FUMONISINS - NOVEL MYCOTOXINS WITH CANCER-PROMOTING ACTIVITY PRODUCED BY FUSARIUM-MONILIFORME
    GELDERBLOM, WCA
    JASKIEWICZ, K
    MARASAS, WFO
    THIEL, PG
    HORAK, RM
    VLEGGAAR, R
    KRIEK, NPJ
    [J]. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1988, 54 (07) : 1806 - 1811
  • [5] TOXICITY AND CARCINOGENICITY OF THE FUSARIUM-MONILIFORME METABOLITE, FUMONISIN-B1, IN RATS
    GELDERBLOM, WCA
    KRIEK, NPJ
    MARASAS, WFO
    THIEL, PG
    [J]. CARCINOGENESIS, 1991, 12 (07) : 1247 - 1251
  • [6] GOEL S, 1995, TOXICOLOGIST, V15, P290
  • [7] HANNUN YA, 1986, J BIOL CHEM, V261, P2604
  • [8] Harrison L R, 1990, J Vet Diagn Invest, V2, P217
  • [9] Kwon O. S., 1995, TOXICOLOGIST, V15, P17
  • [10] PRIMARY LIVER-CANCER AND ESOPHAGEAL BASAL-CELL HYPERPLASIA IN RATS CAUSED BY FUSARIUM-MONILIFORME
    MARASAS, WFO
    KRIEK, NPJ
    FINCHAM, JE
    VANRENSBURG, SJ
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1984, 34 (03) : 383 - 387